Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty

• Status: Completed
• Trial end date: 2016-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy of two prophylactic agent(aspirin 300mg/day and rivaroxaban 10mg/day) for venous thromboembolism after total knee arthroplasty.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hanyang University Seoul Hospital
• Treatments: Aspirin; Rivaroxaban

Criteria

Inclusion Criteria:

• all patients undergone primary total knee arthroplasty

Exclusion Criteria:

• renal insufficiency, contrast allergy, simultaneous bilateral TKA, hemorrhagic disorder, sever liver disease